Drug Shortage Report for PMS-TESTOSTERONE
Report ID | 164150 |
Drug Identification Number | 02322498 |
Brand name | PMS-TESTOSTERONE |
Common or Proper name | TESTOSTERONE |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | TESTOSTERONE UNDECANOATE |
Strength(s) | 40MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | CAPS, BLISTER |
ATC code | G03BA |
ATC description | ANDROGENS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-07-05 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2022-07-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2022-07-06 | English | Compare |
v2 | 2022-07-05 | French | Compare |
v1 | 2022-07-05 | English | Compare |
Showing 1 to 3 of 3